Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reed

Showing results (731-740 of 781) with videos related to

Pageof 79
Sort By:
Transplantation|June 20, 2018
Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant RecipientsQiuheng Zhang, Michelle Hickey, Diana Drogalis-Kim, et al.
Journal of Clinical Medicine|June 19, 2024
An Exercise Immune Fitness Test to Unravel Disease Mechanisms-A Proof-of-Concept Heart Failure StudyGalyna Bondar, Abhinandan Das Mahapatra, Tra-Mi Bao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell TransplantationJeanette E Boudreau, Fabio Giglio, Ted A Gooley, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2024
Group 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gamma-mediated pathwayHidenobu Kojima, Thomas A Morinelli, Yue Wang, et al.
JDS Communications|January 7, 2026
The Ruminant Farm Systems (RuFaS) model is a platform to support future research and actions for sustainable dairy farmingK F Reed, J M Tricarico, S HekmatiAthar, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
Hepatology (Baltimore, Md.)|May 20, 2020
Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver TransplantationRebecca A Sosa, Allyson Q Terry, Fady M Kaldas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Human Immunology|December 20, 2025
Prolonged wait times among highly sensitized HLA-B46 homozygous kidney transplant candidatesCarrie L Butler, Loren Gragert, Anh Du, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2021
The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantationMichael Y Shino, Qiuheng Zhang, Ning Li, et al.
Pageof 79

Showing results (731-740 of 781) with videos related to

Sort By:
Pageof 79
Transplantation|June 20, 2018
Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant RecipientsQiuheng Zhang, Michelle Hickey, Diana Drogalis-Kim, et al.
Journal of Clinical Medicine|June 19, 2024
An Exercise Immune Fitness Test to Unravel Disease Mechanisms-A Proof-of-Concept Heart Failure StudyGalyna Bondar, Abhinandan Das Mahapatra, Tra-Mi Bao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell TransplantationJeanette E Boudreau, Fabio Giglio, Ted A Gooley, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2024
Group 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gamma-mediated pathwayHidenobu Kojima, Thomas A Morinelli, Yue Wang, et al.
JDS Communications|January 7, 2026
The Ruminant Farm Systems (RuFaS) model is a platform to support future research and actions for sustainable dairy farmingK F Reed, J M Tricarico, S HekmatiAthar, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
Hepatology (Baltimore, Md.)|May 20, 2020
Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver TransplantationRebecca A Sosa, Allyson Q Terry, Fady M Kaldas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Human Immunology|December 20, 2025
Prolonged wait times among highly sensitized HLA-B46 homozygous kidney transplant candidatesCarrie L Butler, Loren Gragert, Anh Du, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2021
The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantationMichael Y Shino, Qiuheng Zhang, Ning Li, et al.
Pageof 79